Generic drug
Zidovudine price, strengths & recalls
Pharmacies pay $13.91 for 30 tablets of Zidovudine 300 mg tablet this week. 3 manufacturers make it. It has 3 recalls on record, none ongoing. Its official label last changed on February 17, 2025.
Generic- Fair cash price
- $26.50
- Strengths
- 1
- Makers
- 3
- Updated
- Nov 11
Zidovudine price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay | ||
|---|---|---|---|---|
| 100 mg capsule | Not priced this week | |||
| 10 mg/mL oral solution | Not priced this week | |||
| 300 mg tablet | $0.4638 | $13.91 / 30 tablets | ||
Supply status: shortages & recalls
Recalls
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Zidovudine
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use ZIDOVUDINE CAPSULES safely and effectively. See full prescribing information for ZIDOVUDINE CAPSULES. ZIDOVUDINE capsules, for oral use Initial U.S. Approval: 1987
WARNING: RISK OF HEMATOLOGICAL TOXICITY, MYOPATHY, LACTIC ACIDOSIS AND SEVERE HEPATOMEGALY WITH STEATOSIS
Zidovudine capsules have been associated with hematologic toxicity including neutropenia and severe anemia, particularly in patients with advanced HIV-1 disease [see Warnings and Precautions (5.1)].
Prolonged use of zidovudine has been associated with symptomatic myopathy [see Warnings and Precautions (5.2)].
Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, have been reported with the use of nucleoside analogues alone or in combination, including zidovudine and other antiretrovirals. Suspend treatment if clinical or laboratory findings suggestive of lactic acidosis or pronounced hepatotoxicity occur [see Warnings and Precautions (5.3)].
WARNING: RISK OF HEMATOLOGICAL TOXICITY, MYOPATHY, LACTIC ACIDOSIS AND SEVERE HEPATOMEGALY WITH STEATOSIS
See full prescribing information for complete boxed warning.
Hematologic toxicity including neutropenia and severe anemia have been associated with the use of zidovudine. (5.1)
Symptomatic myopathy associated with prolonged use of zidovudine. (5.2)
Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, have been reported with the use of nucleoside analogues including zidovudine. Suspend treatment if clinical or laboratory findings suggestive of lactic acidosis or pronounced hepatotoxicity occur. (5.3)
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Generic makers
- 4 approved generic applications on the market
Zidovudine questions
How much does zidovudine cost without insurance?
Pharmacies pay about $13.91 for 30 tablets of zidovudine 300 mg tablet ($0.4638 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $26.50. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is zidovudine in shortage?
No shortage is reported for zidovudine right now. We check the national shortage list every day.
Has zidovudine been recalled?
3 recalls on record, none ongoing. Recalls name specific lots - check yours.
When did the zidovudine label last change?
The official label was last updated on February 17, 2025 (version 19). See what changed.
Talk about zidovudine
No comments yet. Questions, tips, what worked for you - start the conversation.